WaveMan
WaveMan · Company
CDT · Cdt Equity Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

CDT CDT Equity (CDT) Insider Trading, Ownership & Congress Trades

Pharma & Biotech · Pharmaceutical preparations · CIK 0001896212
Quote by TradingView
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
8
13F, latest reported quarter

What the filings say about CDT

Insiders, 180 days
-$2.9M net sold
1 seller · 0% of sales under a 10b5-1 plan

CDT Equity insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, CDT Equity Inc. insiders sold a net $2.9M of stock across 22 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
Regan Andrew
Chief Executive Officer
SELL
2026-09-02 SECtraded 2026-08-28
290
-
-99.5%
Regan Andrew
Chief Executive Officer
SELL
2026-10-27 SECtraded 2026-08-28
29
-
n/a
Prospect Capital Securities Ltd
SELL
2026-06-23 SECtraded 2026-06-18
5,000
$3.8K
-91.4%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 0.8% of the 593,289 shares held after it.
  • No other insider sold within 30 days.
  • 8 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Prospect Capital Securities Ltd sold about $3.8K of CDT on Jun 18, 2026, the largest insider sale at the company since 2024; 8 funds added in the latest 13F quarter.
Prospect Capital Securities Ltd
SELL
2026-06-23 SECtraded 2026-06-18
1,464,711
$2.1M
-91.4%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • No other insider sold within 30 days.
  • 8 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Prospect Capital Securities Ltd sold about $2.1M of CDT on Jun 18, 2026, the largest insider sale at the company since 2024; 8 funds added in the latest 13F quarter.
Prospect Capital Securities Ltd
SELL
2026-06-23 SECtraded 2026-06-18
593,289
$830.6K
-91.4%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • No other insider sold within 30 days.
  • 8 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Prospect Capital Securities Ltd sold about $830.6K of CDT on Jun 18, 2026, the largest insider sale at the company since 2024; 8 funds added in the latest 13F quarter.
22 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 17 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$2.9M over 180 days
-$2.9M of it by a 10%+ holder
below 73% of Pharma & Biotech
Congress
no House purchase disclosed in the last 12 months
Funds
8 funds bought in last quarter
below 89% of Pharma & Biotech
Revenue
no revenue reported in any filing
Margin
no margin: no revenue reported
Buybacks
$106.0K repurchased, FY to 2025-12-31
below 96% of Pharma & Biotech
Short interest
4.9% of shares outstanding short · 1.0 days to cover · settled 2026-09-30
more than 50% of Pharma & Biotech
What changed in the last 30 days
Oct 28Insider selling stopped: no sales in 90 days after 4 in the prior 90
Why it matters
The absence is the signal: 4 sales in one 90-day window and none in the next is a change of behaviour, not a filing.

Watch CDT

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-99.9%12M
-100%-67%-33%+0%2025-102025-122026-022026-042026-062026-082026-10 2026-06-18 · Prospect Capital Securities Ltd sold $2.1M2026-06-18 · Prospect Capital Securities Ltd sold $830.6K2026-06-18 · Prospect Capital Securities Ltd sold $3.8K2026-06-18 · Prospect Capital Securities Ltd sold $3.5K2026-08-28 · Regan Andrew sold -2026-08-28 · Regan Andrew sold -2026-03-30 · Taylor Mark Andrew filed a 5%+ stake (43.79%)2026-03-30 · Prospect Capital Securities Ltd filed a 5%+ stake (31.12%)2026-03-30 · Prospect Finance Ltd filed a 5%+ stake (12.67%)
Insider sell13D/G stake
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns CDT: institutional holders (13F)

13F holdings, latest reported quarter
BOOTHBAY FUND MANAGEMENT, LLC
250,000 sh
$140.0K
JANE STREET GROUP, LLC
61,190 sh
$34.3K
CITADEL ADVISORS LLC
32,295 sh
$18.1K
Polar Asset Management Partners Inc.
950,000 sh
$13.9K
Saba Capital Management, L.P.
765,000 sh
$12.5K

Congress trades in CDT

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

13D: intends to influence · 13G: passive
Taylor Mark Andrew
Activist 13D · 2026-03-30
43.79%
Prospect Capital Securities Ltd
Activist 13D · 2026-03-30
31.12%
Prospect Finance Ltd
Activist 13D · 2026-03-30
12.67%

CDT planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.

CDT mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Fidelity Extended Market Index Fund
$4.0K position · as of 2026-05-31
0.0%
Fidelity Nasdaq Composite Index Fund
$2.0K position · as of 2026-05-31
0.0%
Fidelity Series Total Market Index Fund
$52 position · as of 2026-05-31
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $2.9M sold by insiders over 180 days, 8 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
UTHRCPIXMRNAREGNLLYALNYMDGLCITRDNAVRTXNUVLTWST

CDT financials

Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Free cash flow, TTM
-$11.9M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
n/a
no debt line filed
Cash flow to debt
n/a
no debt line filed
Return on equity
-69.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
-55.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
effective tax rate 52%, not meaningful
Return on capital employed
-65.2%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Enterprise value
n/a
no debt line filed
FCF yield
-16,068%
TTM free cash flow over market value at close 2026-10-26
PEG, trailing
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Operating income-$36.8M-$15.4M-$5.3M-$3.2M
Net income-$39.2M-$17.8M-$535.0K-$4.9M
EPS (diluted)-11,779.12-612,360.21-8.92-0.13
Operating cash flow-$15.6M-$9.7M-$7.7M-$2.3M
Cash$1.5M$554.0K$4.2M$345.8K
Buybacks$106.0Kn/an/an/a
SEC XBRL, fiscal years, as known on 2026-10-28

CDT Stock Sonar score 4/7 axes

Find similar shapesCompare

CDT ranks highest on risk and compliance (59th percentile) and profitability (41st), and lowest on institutional and government (11th), among Pharma & Biotech peers.

Profitability
41
Inputs
  • Return on equity-69.7% · 43 pct, sector of 545
  • Return on assets-55.2% · 41 pct, sector of 691
  • Return on invested capitaleffective tax rate 52%, not meaningful
  • Return on capital employed-65.2% · 38 pct, sector of 576
Insider conviction
12
Inputs
  • Net Form 4 buying (codes P and S), 180d-$2.9M · 24 pct, sector of 428
  • Insider buyers, 180d0 · 0 pct, sector of 437
Institutional and government
11
Inputs
  • Funds adding, latest quarter8 · 11 pct, sector of 698
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
59
Inputs
  • Short interest, % of shares outstanding (no float on file)+4.9% · 59 pct, sector of 813
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
3 not measured: Financial health, Growth, US patents
  • Financial health needs 1 of 2 inputs, 0 present: no debt line filed
  • Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

CDT filings, in plain words

Are CDT Equity insiders buying or selling CDT?

In the 180 days to 2026-10-28, CDT Equity insiders were net sellers, a net $2.9M across purchases and sales reported on Form 4, by 1 seller.

Read the full summary

In the 180 days to 2026-10-28, CDT Equity insiders were net sellers of CDT, a net $2.9M across purchases and sales reported on Form 4 by 1 seller. Most of that figure, $2.9M, came from a holder of 10% or more rather than an officer or director. None of the 6 insider sales was flagged as made under a Rule 10b5-1 plan. The latest 5% ownership filing is a 13D by Taylor Mark Andrew, filed 2026-03-30, for 43.8% of the class. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies